Neurotech International (NTI) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock NTI Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Neurotech International Relocates Headquarters to MelbourneJuly 10, 2025 | tipranks.comNeurotech’s cannabinoid drug reports positive results from key studyJune 2, 2025 | msn.comAussie researchers and ASX biotechs driving paediatric drug breakthroughsMay 22, 2025 | msn.comNeurotech’s NTI164 shows excellent tolerability in key preclinical toxicology studiesMay 5, 2025 | msn.comNeurotech International Updates Trading Policy to Enhance ComplianceApril 15, 2025 | tipranks.comKRTL Holding Announces Acquisition of Neurogen Brain Balancing, LLC – A Strategic Merger Accelerating Global Neurotech and Mental Wellness ExpansionApril 11, 2025 | markets.businessinsider.comNeurotech International Issues New Shares, Ensures Regulatory ComplianceApril 2, 2025 | tipranks.comNeurotech’s NTI164 Receives EU Orphan Drug Designation for Rett SyndromeMarch 30, 2025 | tipranks.comNeurotech International Unveils Strategic Plans at NWR Virtual Healthcare ConferenceMarch 19, 2025 | tipranks.comHere's Why Neurotech International (ASX:NTI) Must Use Its Cash WiselyMarch 8, 2025 | finance.yahoo.comRare opportunities – ASX health stocks tackling unmet medical needsFebruary 13, 2025 | msn.comIs There Now An Opportunity In Neurotech International Limited (ASX:NTI)?December 6, 2024 | finance.yahoo.comNeurotech Director Increases Shareholding in CompanyDecember 6, 2024 | markets.businessinsider.comNeurotech International’s AGM Success and Trial ProgressNovember 20, 2024 | markets.businessinsider.comNeurotech’s NTI164 Shows Promise in Neurological TreatmentNovember 12, 2024 | markets.businessinsider.comDr Anthony Filippis to helm Neurotech as it advances its NTI164 strategy in 2025November 11, 2024 | msn.comNeurotech International Appoints New CEO to Drive GrowthNovember 10, 2024 | markets.businessinsider.comNeurotech International to Issue 20 Million OptionsNovember 10, 2024 | markets.businessinsider.comEstimating The Intrinsic Value Of Neurotech International Limited (ASX:NTI)October 26, 2024 | uk.finance.yahoo.comNeurotech International Advances in Neurological Disorder TreatmentsOctober 22, 2024 | markets.businessinsider.comNeurotech knocked back by FDA as agency declares target condition not rare enough for special statusOctober 4, 2024 | msn.comWe're Not Very Worried About Neurotech International's (ASX:NTI) Cash Burn RateSeptember 30, 2024 | finance.yahoo.comAustralia proves its reputation as ‘go-to’ destination for clinical trialsSeptember 18, 2024 | msn.comNeurotech International Ltd Investor Webinar TranscriptSeptember 14, 2024 | gurufocus.comNeurotech International Ltd Rett Syndrome Phase I Or II Trial Results Webinar TranscriptSeptember 14, 2024 | gurufocus.comBreak it Down: Neurotech gives something to think aboutSeptember 9, 2024 | msn.comNeurotech’s cannabinoid drug reverses immune dysregulation in PANDAS/PANS kidsSeptember 9, 2024 | msn.comThe 18% return this week takes Neurotech International's (ASX:NTI) shareholders five-year gains to 500%August 19, 2024 | finance.yahoo.comNeurotech’s Rett Syndrome trial shows improvement in extension stageJuly 31, 2024 | msn.comNeurotech Phase 2/3 autism trial shows uplift in mood while lowering anxiety and depressionJuly 19, 2024 | msn.comDespite Setback, Neuralink’s First Brain-Implant Patient Stays UpbeatMay 22, 2024 | nytimes.comNTI 2024: Flosonics Medical Presents Educational Dinner Symposium on the Future of Sepsis ResuscitationMay 17, 2024 | markets.businessinsider.comNeuralink's first patient said he 'cried a little bit' after his brain implant started malfunctioningMay 16, 2024 | msn.comNeurotech reports more positive Phase 1/2 Rett Syndrome clinical trial resultsMay 6, 2024 | msn.comPharmAust plans for pivotal Phase 2/3 trial after key quarter of milestonesApril 30, 2024 | msn.comNeurotech’s Phase 2/3 autism trial meets primary endpointApril 17, 2024 | msn.comNeurotech hits new milestone in Phase II/III autism trial after treating last patientApril 10, 2024 | msn.comNeuroVigil, World's Most Valuable Neurotech, Launches iBrain™ in USApril 5, 2024 | tmcnet.comNeuroVigil, World's Most Valuable Neurotech Company, Launches in USApril 4, 2024 | tmcnet.comNeurotech extends clinical trials for the $US2bn Rett Syndrome marketMarch 13, 2024 | msn.comNeurotech International's (ASX:NTI) investors will be pleased with their massive 340% return over the last five yearsFebruary 27, 2024 | finance.yahoo.comMarket Highlights: Chipmaker Arm up 29pc, Bitcoin tops US$50k, and 5 ASX small caps to watch todayFebruary 13, 2024 | msn.comMicroPort NeuroTech Ltd 02172February 7, 2024 | morningstar.comMNeurotech gets green light to start phase I/II cerebral palsy trialJanuary 28, 2024 | msn.comNeurotech moves to show economic advantage of autism treatment as Phase II/III trial results due soonJanuary 24, 2024 | msn.comWhat’s in store for 2024: Neurotech InternationalJanuary 16, 2024 | msn.comPart 1: ASX biotechs with catalysts looking to pop in 2024December 26, 2023 | msn.comNeurotech completes recruitment in Phase 2/3 autism spectrum disorder trialDecember 18, 2023 | msn.comNeurotech to extend Phase 2/3 autism spectrum disorder trial to adultsDecember 3, 2023 | msn.comNeurotech treatment looks to be making a difference in children with PANDAS/PANS in Phase I/II clinical trialOctober 8, 2023 | msn.com Get Neurotech International News Delivered to You Automatically Sign up to receive the latest news and ratings for NTI and its competitors with MarketBeat's FREE daily newsletter. Email Address NTI Media Mentions By Week NTI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NTI News Sentiment▼0.000.46▲Average Medical News Sentiment NTI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NTI Articles This Week▼00▲NTI Articles Average Week Get Neurotech International News Delivered to You Automatically Sign up to receive the latest news and ratings for NTI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Evolution Petroleum News Ring Energy News Gran Tierra Energy News Global X Active Canadian Dividend ETF Common News Amplify Energy News Prairie Operating News Epsilon Energy News Intermap Technologies News Mammoth Energy Services News Enterprise Group News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:NTI) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurotech International Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Neurotech International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NTI Stock Alerts